Our team of experts brings you cancer-related news and research updates.
Phyllis Alsterberg was recently treated for non-Hodgkin lymphoma. She hasn’t left her home in New York City much since the coronavirus outbreak started because she has a weakened immune system and she’s worried about getting sick.
To help both the death and diagnosis rates of colorectal cancer drop—and to help those who develop it survive and thrive—the American Cancer Society (ACS) funds the research of scientists across the country who use the latest evidence and cutting-edge technology to help prevent and treat CRC. Here are two of their stories.
Brian Glennon says he’s still the same Sinatra-loving, Broadway-going, basketball-coaching 63-year-old man who is grateful for the love of his family. Glennon was diagnosed with prostate cancer after a higher-than-average PSA result prompted him and his doctor to monitor his PSA level more closely.
Owen A. O'Connor, MD, PhD, was awarded the prestigious American Cancer Society Clinical Research Professor grant in July 2018. He was selected because of his expertise and ongoing work to develop drugs to improve treatments for people with Hodgkin and non-Hodgkin lymphomas. He's a professor and researcher at the Herbert Irving Comprehensive Cancer Center at Columbia University Medical Center in New York, New York.
Two studies examine whether exposure to chemicals from the wreckage of the World Trade Center during rescue and recovery work after the September 11, 2001 attacks increased firefighters’ risk of developing cancer.